A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleA Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsJaeHee Cheon, Jong Hak Kim, Hyunsoo Kim